Abstract
The outbreak of coronavirus diseases (COVID-19) has rabidly spread all over the world. The World Health Organization (WHO) has announced that coronavirus COVID-19 is an international pandemic. The Real-Time Reverse transcription-polymerase Chain Reaction (RT-PCR) has a low positive and sensitivity rate in the early stage of COVID-19. As a result, the Computed Tomography (CT) imaging is used for diagnosing. COVID-19 has different key signs on a CT scan differ from other viral pneumonia. These signs include ground-glass opacities, consolidations, and crazy paving. In this paper, an Artificial Intelli-gence-inspired Model for COVID-19 Diagnosis and Prediction for Patient Response to Treatment (AIMDP) is proposed. AIMDP model has two main functions reflected in two proposed modules, namely, the Diagnosis Module (DM) and Prediction Module (PM). The Diagnosis Module (DM) is proposed for early and accurately detecting the patients with COVID-19 and distinguish it from other viral pneumonias using COVID-19 signs obtained from CT scans. The DM model, uses Convolutional Neural Networks (CNNs) as a Deep learning technique for segmentation, can process hundreds of CT images in seconds to speed up diagnosis of COVID-19 and contribute in its containment. In addition, some countries haven’t the ability to provide all patients with the treatment and intensive care services, so it will be mandatory to give treatment to only responding patients. In this context, the Prediction Module (PM) is proposed for predicting the ability of the patient to respond to treatment based on different factors e.g. age, infection stage, respiratory failure, multi-organ failure and the treatment regimens. PM implement the Whale Optimization Algorithm for selecting the most relevant patient’s features. The experimental results show promising performance for the proposed diagnosing and prediction modules, using a dataset with hundreds of real data and CT images.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There is no Funding applied
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The CT images dataset firstly collected from https://github.com/UCSD-AI4H/COVID-CT, https://www.sirm.org/en/, and https://github.com/ieee8023/covid-chestxray-dataset. Then the CT images are segmented, updated and analyzed to generate a new dataset which is available from the corresponding author on reasonable request.
https://github.com/ieee8023/covid-chestxray-dataset
